Breast cancer stem-like cells specific vulnerabilities: focus in HER2 over-expression and protein glycosylation

Project Information

BCSC-ST

Grant agreement ID: 745808

DOI

10.3030/745808

Project terminated on 2 June 2018

EC signature date 27 February 2017

Start date 1 March 2017

End date 28 February 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 195 454,80

EU contribution

€ 195 454,80

Coordinated by

UNIVERSITY OF NEWCASTLE UPON TYNE
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy

Author(s): Ruth Rodriguez-Barrueco, Erin A. Nekritz, François Bertucci, Jiyang Yu, Felix Sanchez-Garcia, Tizita Z. Zeleke, Andrej Gorbatenko, Daniel Birnbaum, Elena Ezhkova, Carlos Cordon-Cardo, Pascal Finetti, David Llobet-Navas, Jose M. Silva
Published in: Genes & Development, Issue 31/6, 2017, Page(s) 553-566, ISSN 0890-9369
Publisher: Cold Spring Harbor Laboratory Press
DOI: 10.1101/gad.292318.116